Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umang Swami

Showing results (81-90 of 170) with videos related to

Pageof 17
Sort By:
European Urology|March 12, 2025
T-cell Engagers in Prostate CancerChadi Hage Chehade, Zeynep Irem Ozay, Micah Ostrowski, et al.
Cancers|November 14, 2023
Access to Care and Healthcare Quality Metrics for Patients with Advanced Genitourinary Cancers in Urban versus Rural AreasHaoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, et al.
The Oncologist|March 23, 2023
Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell CarcinomaHaoran Li, Kamal Kant Sahu, James Brundage, et al.
Oncotarget|November 29, 2017
Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb studyYousef Zakharia, Varun Monga, Umang Swami, et al.
Heliyon|September 19, 2022
A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancersHaoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, et al.
Prostate Cancer and Prostatic Diseases|July 14, 2025
Cardiovascular risks in men with prostate cancer: a pragmatic, clinician-oriented review of risk stratification and management strategiesAditya Bhave, Harikrishnan Hyma Kunhiraman, Tarek Nahle, et al.
CA: a Cancer Journal for Clinicians|January 10, 2025
A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitorsChadi Hage Chehade, Georges Gebrael, Nicolas Sayegh, et al.
Journal for Immunotherapy of Cancer|January 27, 2021
Real-world experience with elective discontinuation of PD-1 inhibitors at 1 year in patients with metastatic melanomaRebecca Pokorny, Jordan P McPherson, Benjamin Haaland, et al.
Journal of Kidney Cancer and VHL|August 5, 2024
Clinical, Genomic, and Transcriptomic Characteristics of Patients with Metastatic Renal Cell Carcinoma Who Developed Thromboembolic EventsGliceida Galarza Fortuna, Beverly Chigarira, Vinay Mathew Thomas, et al.
Cancers|April 3, 2021
Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor TherapyJohn M Rieth, Umang Swami, Sarah L Mott, et al.
Pageof 17

Showing results (81-90 of 170) with videos related to

Sort By:
Pageof 17
European Urology|March 12, 2025
T-cell Engagers in Prostate CancerChadi Hage Chehade, Zeynep Irem Ozay, Micah Ostrowski, et al.
Cancers|November 14, 2023
Access to Care and Healthcare Quality Metrics for Patients with Advanced Genitourinary Cancers in Urban versus Rural AreasHaoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, et al.
The Oncologist|March 23, 2023
Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell CarcinomaHaoran Li, Kamal Kant Sahu, James Brundage, et al.
Oncotarget|November 29, 2017
Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb studyYousef Zakharia, Varun Monga, Umang Swami, et al.
Heliyon|September 19, 2022
A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancersHaoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, et al.
Prostate Cancer and Prostatic Diseases|July 14, 2025
Cardiovascular risks in men with prostate cancer: a pragmatic, clinician-oriented review of risk stratification and management strategiesAditya Bhave, Harikrishnan Hyma Kunhiraman, Tarek Nahle, et al.
CA: a Cancer Journal for Clinicians|January 10, 2025
A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitorsChadi Hage Chehade, Georges Gebrael, Nicolas Sayegh, et al.
Journal for Immunotherapy of Cancer|January 27, 2021
Real-world experience with elective discontinuation of PD-1 inhibitors at 1 year in patients with metastatic melanomaRebecca Pokorny, Jordan P McPherson, Benjamin Haaland, et al.
Journal of Kidney Cancer and VHL|August 5, 2024
Clinical, Genomic, and Transcriptomic Characteristics of Patients with Metastatic Renal Cell Carcinoma Who Developed Thromboembolic EventsGliceida Galarza Fortuna, Beverly Chigarira, Vinay Mathew Thomas, et al.
Cancers|April 3, 2021
Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor TherapyJohn M Rieth, Umang Swami, Sarah L Mott, et al.
Pageof 17